We are live on ! Find out more
SCP

Shorepoint Capital Partners Portfolio holdings

AUM $503M
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
+$6.59M
Cap. Flow
-$4.83M
Cap. Flow %
-2.58%
Top 10 Hldgs %
32.6%
Holding
82
New
6
Increased
33
Reduced
34
Closed
5

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.95M
2
ABT icon
Abbott
ABT
+$1.71M
3
JPM icon
JPMorgan Chase
JPM
+$922K
4
PNC icon
PNC Financial Services
PNC
+$868K
5
PFE icon
Pfizer
PFE
+$740K

Sector Composition

Rank Sector Weight
1 Healthcare 17.6%
2 Technology 13.02%
3 Financials 11.46%
4 Industrials 8.56%
5 Consumer Staples 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHD icon
1
Schwab US Dividend Equity ETF
SCHD
$100B
$12.2M 6.54%
503,442
+3,690
+0.7% +$83.9K
SCHG icon
2
Schwab US Large-Cap Growth ETF
SCHG
$59.7B
$7.37M 3.94%
454,128
-5,096
-1% -$82.9K
VB icon
3
Vanguard Small-Cap ETF
VB
$79.7B
$5.96M 3.18%
27,817
+1,324
+5% +$279K
CVS icon
4
CVS Health
CVS
$137B
$5.46M 2.92%
72,560
-314
-0.4% -$22.9K
ABBV icon
5
AbbVie
ABBV
$450B
$5.28M 2.82%
48,743
-27,620
-36% -$2.95M
JPM icon
6
JPMorgan Chase
JPM
$907B
$5.27M 2.82%
34,623
-6,407
-16% -$922K
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$5.26M 2.82%
32,035
+661
+2% +$107K
AVGO icon
8
Broadcom
AVGO
$1.76T
$4.95M 2.65%
106,740
-2,330
-2% -$108K
AAPL icon
9
Apple
AAPL
$4.9T
$4.7M 2.51%
38,500
-2,046
-5% -$263K
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$4.49M 2.4%
71,051
+6,099
+9% +$379K
PNC icon
11
PNC Financial Services
PNC
$101B
$4.45M 2.38%
25,390
-5,260
-17% -$868K
QCOM icon
12
Qualcomm
QCOM
$181B
$4.08M 2.18%
30,811
+1,525
+5% +$220K
VO icon
13
Vanguard Mid-Cap ETF
VO
$106B
$4.04M 2.16%
73,032
+844
+1% +$45.8K
JMST icon
14
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.02B
$4.03M 2.15%
78,925
+59,950
+316% +$3.06M
LOW icon
15
Lowe's Companies
LOW
$117B
$3.87M 2.07%
20,327
-451
-2% -$77.4K
TT icon
16
Trane Technologies
TT
$104B
$3.63M 1.94%
21,906
-1,008
-4% -$156K
PEP icon
17
PepsiCo
PEP
$187B
$3.62M 1.94%
25,615
+1,438
+6% +$197K
CMCSA icon
18
Comcast
CMCSA
$85B
$3.49M 1.86%
64,439
-2,121
-3% -$112K
MRK icon
19
Merck
MRK
$315B
$3.48M 1.86%
47,256
+8,990
+23% +$663K
VFC icon
20
VF Corp
VFC
$6.66B
$3.45M 1.84%
43,115
-279
-0.6% -$22.6K
SJM icon
21
J.M. Smucker
SJM
$12B
$3.35M 1.79%
26,452
+787
+3% +$92.9K
CSCO icon
22
Cisco
CSCO
$441B
$3.34M 1.79%
64,553
-1,911
-3% -$89.7K
TRV icon
23
Travelers Companies
TRV
$78.5B
$3.25M 1.74%
21,601
-1,894
-8% -$278K
MDT icon
24
Medtronic
MDT
$106B
$3.16M 1.69%
26,741
+1,941
+8% +$227K
ETN icon
25
Eaton
ETN
$155B
$3.13M 1.67%
22,639
-650
-3% -$83.8K

Similar funds

Shorepoint Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Shorepoint Capital Partners held 82 positions worth $187M, up 3.7% from $180M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Shorepoint Capital Partners's Q1 2021 filing shows 6 new, 33 increased, 34 reduced and 5 closed positions. Its largest new stake was American Tower: 3,421 shares worth $818K. The largest sale was AbbVie, an estimated $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Shorepoint Capital Partners's largest Q1 2021 buy was American Tower: 3,421 shares worth $818K.
  • Shorepoint Capital Partners added most to JPMorgan Ultra-Short Municipal Income ETF in Q1 2021, an estimated $3.06M increase.
  • Shorepoint Capital Partners's biggest Q1 2021 reduction was AbbVie, cutting an estimated $2.95M.
  • Shorepoint Capital Partners fully exited Pfizer in Q1 2021, selling an estimated $740K.
  • Shorepoint Capital Partners's ten largest holdings make up 33% of its $187M portfolio in Q1 2021.
  • Shorepoint Capital Partners opened 6 new positions and closed 5 in Q1 2021.
  • Shorepoint Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $187M.

Based on Shorepoint Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.